✦ LIBER ✦

ALK inhibitors in the treatment of advanced NSCLC

✍ Scribed by Gridelli, Cesare; Peters, Solange; Sgambato, Assunta; Casaluce, Francesca; Adjei, Alex A.; Ciardiello, Fortunato

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ALK inhibitors: a new targeted therapy i

✍ Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 258 KB

Gemcitabine and treatment of advanced NS

✍ van Zandwijk, Nico 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Clinical benefit of continuing ALK inhib

✍ Ou, S.- H. I.; Janne, P. A.; Bartlett, C. H.; Tang, Y.; Kim, D.- W.; Otterson, G 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 160 KB

Targeted therapies in the treatment of a

✍ A.G. Pallis; L. Serfass; R. Dziadziuszko; J.P. van Meerbeeck; D. Fennell; D. Lac 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 236 KB

The Hsp90 inhibitor IPI-504 rapidly lowe

✍ Normant, E; Paez, G; West, K A; Lim, A R; Slocum, K L; Tunkey, C; McDougall, J; 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 397 KB

Differential sensitivities to tyrosine k

✍ Lee, June Koo; Kim, Tae Min; Koh, Youngil; Lee, Se-Hoon; Kim, Dong-Wan; Jeon, Yo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 359 KB